Prevalence rate of the MS and its components (n = 184)
| . | No. (%) of subjects (n = 184) . | 95% CI of the population . |
|---|---|---|
| MS NCEP-ATPIII | 17 (9.2) | 5.5-14.4 |
| Reduced HDL cholesterol | 55 (31.8) | 24.9-39.3 |
| Elevated triglycerides | 24 (13.0) | 8.5-18.8 |
| Elevated fasting glucose | 10 (5.7) | 2.8-10.3 |
| Elevated blood pressure | 41 (25.3) | 18.8-32.7 |
| Elevated waist circumference | 22 (14.5) | 9.2-21.0 |
| . | No. (%) of subjects (n = 184) . | 95% CI of the population . |
|---|---|---|
| MS NCEP-ATPIII | 17 (9.2) | 5.5-14.4 |
| Reduced HDL cholesterol | 55 (31.8) | 24.9-39.3 |
| Elevated triglycerides | 24 (13.0) | 8.5-18.8 |
| Elevated fasting glucose | 10 (5.7) | 2.8-10.3 |
| Elevated blood pressure | 41 (25.3) | 18.8-32.7 |
| Elevated waist circumference | 22 (14.5) | 9.2-21.0 |